We are live on !
Find out more
AQA
Alpha Quant Advisors Portfolio holdings
AUM
$100M
Turnover
32.39%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$3.41M
(+3.5%)
Cap. Flow
-$5.41M
Cap. Flow % of AUM
Cap. Flow %
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
18.21%
Holding
423
New
64
Increased
61
Reduced
101
Closed
73
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$1.17M |
| 2 |
NRG Energy
NRG
|
+$882K |
| 3 |
Southwest Airlines
LUV
|
+$321K |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$268K |
| 5 |
Stryker
SYK
|
+$246K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.6M |
| 2 |
Intuit
INTU
|
+$1.14M |
| 3 |
Delta Air Lines
DAL
|
+$992K |
| 4 |
Biogen
BIIB
|
+$331K |
| 5 |
International Flavors & Fragrances
IFF
|
+$285K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.07% |
| 2 | Technology | 17.89% |
| 3 | Consumer Staples | 15.81% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Regeneron Pharmaceuticals
REGN
$80.5B
| $256K | 0.26% |
624
-136
| -18% | -$56K |
2018 Q4
1 quarter
|
|
102
Merck
MRK
$354B
| $255K | 0.26% |
3,188
-1,562
| -33% | -$117K |
2018 Q4
1 quarter
|
|
103
Edwards Lifesciences
EW
$50.3B
| $254K | 0.25% |
3,978
-783
| -16% | -$44.7K |
2018 Q4
1 quarter
|
|
104
Quest Diagnostics
DGX
$25.9B
| $252K | 0.25% |
+2,807
| New | +$243K |
2019 Q1
0 quarters
|
|
105
Wells Fargo
WFC
$246B
| $251K | 0.25% |
5,200
| – | – |
2018 Q4
1 quarter
|
|
106
Costco
COST
$441B
| $250K | 0.25% |
1,033
+919
| +806% | +$201K |
2018 Q4
1 quarter
|
|
|
AGN
107
DELISTED
Allergan plc
AGN
| $248K | 0.25% |
1,693
-67
| -4% | -$9.7K |
2018 Q4
1 quarter
|
|
108
Illumina
ILMN
$39.7B
| $246K | 0.25% |
816
-319
| -28% | -$93K |
2018 Q4
1 quarter
|
|
109
AT&T
T
$159B
| $246K | 0.25% |
10,387
+207
| +2% | +$4.76K |
2018 Q4
1 quarter
|
|
|
SJI
110
DELISTED
South Jersey Industries, Inc.
SJI
| $246K | 0.25% |
7,600
| – | – |
2018 Q4
1 quarter
|
|
111
Nektar Therapeutics
NKTR
$1.25B
| $241K | 0.24% |
477
-322
| -40% | -$191K |
2018 Q4
1 quarter
|
|
112
CMS Energy
CMS
$21.1B
| $240K | 0.24% |
+4,307
| New | +$227K |
2019 Q1
0 quarters
|
|
113
UnitedHealth
UNH
$365B
| $234K | 0.23% |
949
-180
| -16% | -$45.9K |
2018 Q4
1 quarter
|
|
114
Humana
HUM
$49.8B
| $214K | 0.21% |
804
-376
| -32% | -$108K |
2018 Q4
1 quarter
|
|
115
Hormel Foods
HRL
$11.2B
| $208K | 0.21% |
4,646
-3,366
| -42% | -$144K |
2018 Q4
1 quarter
|
|
|
116
Cigna
CI
$78.9B
| $194K | 0.19% |
1,207
-8,750
| -88% | -$1.6M |
2018 Q4
1 quarter
|
|
117
FirstEnergy
FE
$26.2B
| $192K | 0.19% |
+4,624
| New | +$184K |
2019 Q1
0 quarters
|
|
|
ABMD
118
DELISTED
Abiomed Inc
ABMD
| $187K | 0.19% |
654
-75
| -10% | -$24.9K |
2018 Q4
1 quarter
|
|
119
Lowe's Companies
LOW
$110B
| $164K | 0.16% |
1,500
| – | – |
2018 Q4
1 quarter
|
|
120
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$12.6B
| $163K | 0.16% |
1,477
| – | – |
2018 Q4
1 quarter
|
|
121
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $158K | 0.16% |
4,160
| – | – |
2018 Q4
1 quarter
|
|
122
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $157K | 0.16% |
1,814
| – | – |
2018 Q4
1 quarter
|
|
123
iShares MSCI EAFE ETF
EFA
$76.4B
| $96K | 0.1% |
1,470
+1
| +0.1% | +$63 |
2018 Q4
1 quarter
|
|
124
iShares Select Dividend ETF
DVY
$22.9B
| $79K | 0.08% |
802
| – | – |
2018 Q4
1 quarter
|
|
125
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $74K | 0.07% |
740
| – | – |
2018 Q4
1 quarter
|
|
Similar funds
WA
SC
WCM
MG
SCM
LS
CWA
LI
Alpha Quant Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Alpha Quant Advisors held 423 positions worth $100M, up 3.5% from $96.4M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alpha Quant Advisors withdrew a net $5.41M in Q1 2019, closing 73 positions and reducing 101 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $285K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Alpha Quant Advisors opened a new position in Alexion Pharmaceuticals worth $291K.
- Alpha Quant Advisors's largest Q1 2019 buy was Alexion Pharmaceuticals: 2,155 shares worth $291K.
- Alpha Quant Advisors added most to Clorox in Q1 2019, an estimated $1.17M increase.
- Alpha Quant Advisors's biggest Q1 2019 reduction was Cigna, cutting an estimated $1.6M.
- Alpha Quant Advisors fully exited International Flavors & Fragrances in Q1 2019, selling an estimated $285K.
- Alpha Quant Advisors's ten largest holdings make up 18% of its $100M portfolio in Q1 2019.
- Alpha Quant Advisors opened 64 new positions and closed 73 in Q1 2019.
- Alpha Quant Advisors's portfolio value rose 3.5% quarter-over-quarter to $100M.
Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.